The Hemophilia Treatment Market is witnessing sustained growth as a result of ongoing advancements in treatment options and improved patient access to care. Hemophilia, a rare genetic bleeding disorder, has traditionally posed significant challenges for patients, but recent developments in therapies and infrastructure are changing the landscape. Innovative therapies, including gene therapy and extended half-life […]
